Robert E. George

Insider Reports History

Reporting-owner location: Houston, TX
Latest reporting-owner signature: /s/ Jonathan Foster by Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert E. George

Form 4 holding Director

Moleculin Biotech, Inc.

Security class: Stock Options (right to buy)
Shares / value: 165,336
Estimated value
Report date: 12 Nov 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Robert E. George

4 MBRX

Moleculin Biotech, Inc.

Report period: 12 Nov 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Nov 2025, 16:05
Role: Director
Next action: Open filing details

4 MBRX

Moleculin Biotech, Inc.

Report period: 04 Nov 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Nov 2024, 20:03
Role: Director
Next action: Open filing details

4 MBRX

Moleculin Biotech, Inc.

Report period: 26 Dec 2023
Transactions: 1
Transaction value: +$10,000
Accepted by SEC: 27 Dec 2023, 07:31
Role: Director
Next action: Open filing details

4 MBRX

Moleculin Biotech, Inc.

Report period: 25 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 26 May 2023, 17:15
Role: Director
Next action: Open filing details

4 MBRX

Moleculin Biotech, Inc.

Report period: 20 Jun 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 22 Jun 2022, 19:03
Role: Director
Next action: Open filing details

4 MBRX

Moleculin Biotech, Inc.

Report period: 07 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 Jun 2021, 16:25
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .